Dermatologic and Ophthalmic Drugs Advisory Committee - PDFSEARCH.IO - Document Search Engine

Dermatologic and Ophthalmic Drugs Advisory Committee
Results: 196

#	Item
71	U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may Add to Reading List Source URL: www.fda.gov Language: English Dermatologic and Ophthalmic Drugs Advisory Committee Pharmacology Center for Drug Evaluation and Research Food and Drug Administration Pharmaceutical sciences Clinical research
72	U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may Add to Reading List Source URL: www.fda.gov Language: English Clinical research Center for Drug Evaluation and Research New Drug Application Dermatologic and Ophthalmic Drugs Advisory Committee Food and Drug Administration Pharmaceutical sciences Pharmacology
73	SESSION 1: NDA[removed]Bepotastine Besilate Ophthalmic Solution, 1 Add to Reading List Source URL: www.fda.gov Language: English Clinical research Dermatologic and Ophthalmic Drugs Advisory Committee ISTA Pharmaceuticals Center for Drug Evaluation and Research Sodium hyaluronate Food and Drug Administration Health Pharmaceutical sciences
74	Quick Minutes (Confidential - Not to be Released Outside of the Agency) Add to Reading List Source URL: www.fda.gov Language: English Clinical research Dermatologic and Ophthalmic Drugs Advisory Committee ISTA Pharmaceuticals Center for Drug Evaluation and Research Sodium hyaluronate Food and Drug Administration Health Pharmaceutical sciences
75	FOOD AND DRUG ADMINISTRATION (FDA) Add to Reading List Source URL: www.fda.gov Language: English Food and Drug Administration Pharmacology Sodium hyaluronate Dermatologic and Ophthalmic Drugs Advisory Committee ISTA Pharmaceuticals Hyaluronan Glycosaminoglycans Pharmaceutical sciences Clinical research
76	[removed]Federal Register / Vol. 69, No[removed]Tuesday, August 31, [removed]Notices Research Working With Stakeholders on Scientific Opportunities for Facilitating Add to Reading List Source URL: www.fda.gov Language: English - Date: 2004-08-31 08:53:41 Pharmaceutical sciences Center for Biologics Evaluation and Research Oncology Drug Advisory Committee Dermatologic and Ophthalmic Drugs Advisory Committee Food and Drug Administration Clinical research Medicine
77	FOOD AND DRUG ADMINISTRATION (FDA) Center for Drug Evaluation and Research (CDER) Peripheral and Central Nervous System Drugs Advisory Committee Meeting The Great Room, White Oak Conference Center, Food and Drug Administ Add to Reading List Source URL: www.fda.gov Language: English Pharmacology Center for Drug Evaluation and Research United States Department of Health and Human Services Bayer HealthCare Pharmaceuticals Dermatologic and Ophthalmic Drugs Advisory Committee Oncology Drug Advisory Committee Food and Drug Administration Pharmaceutical sciences Clinical research
78	U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may Add to Reading List Source URL: www.fda.gov Language: English Pharmacology Center for Drug Evaluation and Research Oncology Drug Advisory Committee Dermatologic and Ophthalmic Drugs Advisory Committee Food and Drug Administration Pharmaceutical sciences Clinical research
79	ONCOLOGIC DRUGS ADVISORY COMMITTEE MEMBERS (Voting) Add to Reading List Source URL: www.fda.gov Language: English Pharmacology Center for Drug Evaluation and Research Criticism of the Food and Drug Administration Dermatologic and Ophthalmic Drugs Advisory Committee Food and Drug Administration Pharmaceutical sciences Clinical research
80	ONCOLOGIC DRUGS ADVISORY COMMITTEE MEMBERS (Voting) Add to Reading List Source URL: www.fda.gov Language: English Pharmacology Center for Drug Evaluation and Research Criticism of the Food and Drug Administration Dermatologic and Ophthalmic Drugs Advisory Committee Food and Drug Administration Pharmaceutical sciences Clinical research

UPDATE